Taylor Morrison Home Corp is an American residential construction company engaged in residential homebuilding and the development of lifestyle communities... Show more
Taylor Morrison Home Corporation stands as the seventh-largest homebuilder in the United States by closings, with operations concentrated across the Southwest, Southeast, California, and Texas. The company serves a deliberately diversified buyer base—roughly 30% entry-level, 18% first move-up, 29% second move-up, and 23% active adult—which provides a structural buffer against demand shocks in any single consumer segment. This balanced segmentation strategy has drawn praise from analysts at Wolfe Research and Raymond James, who view it as a meaningful differentiator relative to peers more heavily weighted toward entry-level buyers, where incentive competition is fiercest.
TMHC's "land-long" strategy—where the company internally develops land for its communities rather than relying heavily on third-party lot purchases—continues to support gross margins that rank among the stronger in the public homebuilder universe. Even as industry-wide incentives have risen, Taylor Morrison's resort-lifestyle segment has delivered gross margins significantly above the company average, helping partially offset pressure in the entry-level tier. The company's geographic footprint in migration-friendly Sun Belt markets also aligns with long-term demographic tailwinds.
However, competitive threats are intensifying. Larger peers with deeper capital reserves are expanding in TMHC's core markets, and an elevated level of speculative (spec) home inventory across the industry risks triggering pricing wars if absorption rates weaken further. The company's backlog—down approximately 30% year-over-year entering late 2025—signals that order momentum has softened, making the execution of the 2026 community-opening plan particularly consequential.
The single most significant credit-market catalyst for TMHC is the trajectory toward a potential investment-grade rating. S&P Global's positive outlook, affirmed in May 2025, explicitly links an upgrade to the company's ability to sustain debt-to-EBITDA below 1.5x through 2026. Achieving a 'BBB-' rating would lower TMHC's cost of capital, broaden its institutional investor base, and provide a durable competitive advantage in land acquisition and corporate financing. As of March 2025, the company's leverage stood at a conservative 1.2x, offering a roughly 60% cushion relative to S&P's downside threshold.
On the operational front, the planned rollout of more than 100 new communities during 2026 represents a critical growth catalyst. If executed effectively, these openings could reignite closing volumes and partially offset the drag from a shrinking backlog. The company's second-quarter 2025 results, which featured a 4% year-over-year increase in closings to 3,340 homes and adjusted earnings per share of $2.02 that exceeded consensus estimates, demonstrated operational resilience amid challenging conditions. Sustaining that momentum will depend heavily on mortgage rate trends and consumer confidence.
Analyst ratings present a nuanced picture. Barclays maintains an Overweight rating with a $70 price target (adjusted from $71 in February 2026), while Citizens initiated coverage in January 2026 with a Market Outperform rating and a notably bullish $95 target. Conversely, BofA Securities downgraded TMHC to Neutral from Buy in January 2026, citing concerns over weaker 2026 home deliveries. The consensus recommendation across 10 brokerage firms sits at approximately 2.2 on a 1-to-5 scale—firmly in Outperform territory—with the average 12-month price target hovering near $76, implying a meaningful premium to recent trading levels.
The homebuilding sector's near-term fate remains tightly coupled to the interest-rate environment. S&P Global projects the average 30-year fixed mortgage rate to ease from 6.6% in 2025 to 5.6% in 2026. If realized, that decline would represent a powerful tailwind for affordability, potentially unlocking demand from buyers who have been sidelined since the post-pandemic rate surge. However, the same forecast anticipates real GDP growth slowing to 1.5% in 2025 and 1.7% in 2026, with unemployment drifting toward 4.7% by mid-2026—a macro backdrop that could temper home-purchase confidence, particularly among move-up and discretionary buyers.
Tariff policy and input-cost inflation introduce additional uncertainty. Building materials, particularly lumber and imported components, remain susceptible to trade-policy shifts that could erode already-thinning margins. TMHC's elevated spec-home inventory, while useful for meeting quick-turn demand, also exposes the company to carrying costs and potential markdowns if buyer traffic decelerates faster than expected. On the regulatory front, zoning reform efforts in several Sun Belt states could gradually ease land-constraint pressures, though meaningful relief is likely a multi-year story rather than a 2026 event.
The structural housing shortage in the United States—estimated by various industry groups at several million units—provides a long-term underpinning for homebuilder demand. For TMHC, the question is not whether housing demand exists over a multi-year horizon, but whether affordability and consumer sentiment can stabilize quickly enough to support the company's near-term growth ambitions.
Investors seeking a data-driven edge in evaluating TMHC's trajectory may find value in Tickeron's Trend Prediction Engine. This AI-powered forecasting tool is designed to help traders assess whether a stock, ETF, or other asset may exhibit bullish, bearish, or sideways movement over the coming week or month. By analyzing historical patterns and identifying developing trends, the Trend Prediction Engine aims to spotlight possible breakouts or reversals before they fully materialize. The platform includes searchable prediction categories, historical context for each forecast, and alert-oriented functionality that can help users stay attuned to evolving market conditions across a wide range of tradable instruments. Exploring the Trend Prediction Engine may complement traditional fundamental analysis when monitoring TMHC amid shifting housing-market dynamics.
Looking through 2026 and beyond, Taylor Morrison's investment narrative hinges on three interlocking themes. First, the company's capital-allocation discipline—anchored by an anticipated $400 million in share repurchases during 2026—should continue to support earnings per share and return on equity, even as absolute earnings face headwinds. Consensus estimates project 2026 revenue of approximately $7.38 billion and earnings per share around $7.50, both representing year-over-year declines from 2025, though a wide range of analyst estimates (EPS forecasts spanning $6.72 to $9.20) reflects genuine uncertainty about the trajectory of housing demand.
Second, the potential investment-grade credit rating represents a structural catalyst that could re-rate TMHC's valuation multiple over time. The company's debt-to-capitalization ratio, projected by S&P in the 20%–25% range for 2025 and 18%–20% for 2026, compares favorably to many peers and underscores a balance-sheet-first philosophy that management has consistently articulated.
Third, TMHC's long-term growth runway remains supported by favorable demographics—including Millennial and Gen Z household formation—and a chronic undersupply of housing in its core Sun Belt markets. However, competitive threats from larger, better-capitalized builders, evolving work-from-home patterns that could shift geographic demand, and the risk of a more pronounced economic slowdown all warrant careful monitoring. The interplay between these structural tailwinds and cyclical headwinds will likely define TMHC's stock forecast narrative well into 2027 and beyond.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a developer of entry-level and luxury homes
Industry Homebuilding
A.I.dvisor indicates that over the last year, TMHC has been closely correlated with MHO. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if TMHC jumps, then MHO could also see price increases.
| Ticker / NAME | Correlation To TMHC | 1D Price Change % | ||
|---|---|---|---|---|
| TMHC | 100% | N/A | ||
| MHO - TMHC | 74% Closely correlated | -0.79% | ||
| MTH - TMHC | 74% Closely correlated | -1.26% | ||
| KBH - TMHC | 68% Closely correlated | -3.34% | ||
| HOV - TMHC | 59% Loosely correlated | -1.43% | ||
| BZH - TMHC | 49% Loosely correlated | +0.03% | ||
More | ||||
TMHC's Aroon Indicator triggered a bullish signal on August 12, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 274 similar instances where the Aroon Indicator showed a similar pattern. In of the 274 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Momentum Indicator moved above the 0 level on August 06, 2026. You may want to consider a long position or call options on TMHC as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TMHC advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 19 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMHC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
TMHC broke above its upper Bollinger Band on July 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 63, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.068) is normal, around the industry mean (2.110). P/E Ratio (10.797) is within average values for comparable stocks, (19.424). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.512). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.945) is also within normal values, averaging (27.754).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TMHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.